- Home
- CNVS vs ICCM Comparison
CNVS vs ICCM Comparison
Compare CNVS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNVS | ICCM |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 45.5M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNVS | ICCM |
|---|---|---|
| Price | $2.32 | $0.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $9.00 | $2.50 |
| AVG Volume (30 Days) | 146.2K | ★ 375.3K |
| Earning Date | 11-14-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $79,791,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $36.06 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 77.29 | N/A |
| 52 Week Low | $2.24 | $0.59 |
| 52 Week High | $7.39 | $1.66 |
Technical Indicators
Market Signals| Indicator | CNVS | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.74 | 35.83 |
| Support Level | $2.40 | $0.67 |
| Resistance Level | $2.51 | $0.72 |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 34.15 | 4.03 |
Price Performance
Historical ComparisonAbout CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.